1News 1News — your global news briefing, coming soon on iOS & Android
Coming Soon
1News 1News
Top Business Entertainment Sports Technology Politics Science Lifestyle
Back to Business
Canaccord reiterates Niagen Bioscience stock rating on drug launch
Business July 10, 2026 at 11:44 AM

Canaccord reiterates Niagen Bioscience stock rating on drug launch

Investing.com
Read at Investing.com

More Stories
Christopher Nolan Addresses ‘The Odyssey’ Online Backlash
Business
Christopher Nolan Addresses ‘The Odyssey’ Online Backlash

The Odyssey has received hate from those who have not seen the film yet, and Christopher Nolan is now commenting on the …

🇺🇸 Forbes Business 30m ago
Macro Hedge Fund Deem Raised $1 Billion From Abu Dhabi’s ADIC
Business
Macro Hedge Fund Deem Raised $1 Billion From Abu Dhabi’s ADIC

Asfandyar Nadeem’s hedge fund has received about $1 billion in new capital from an Abu Dhabi investor, amid a surge in a…

🇺🇸 Bloomberg Markets 39m ago
Velan Q1 FY2027 slides: sales fall 20% as new owners back transformation
Business
Velan Q1 FY2027 slides: sales fall 20% as new owners back transformation
🇺🇸 Investing.com 44m ago
1News
Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play
1News 1News

Your global news briefing — 300+ sources, 12 countries, 10 languages.

Support 1News Settings Search AI Info

© 2026 1News. The world's news, curated for you.